Edward Morrow Atkinson III insider trades

Open-market stock purchases and sales by Edward Morrow Atkinson III, EVP, Chief Technical Ops. Off. at Vertex Pharmaceuticals Inc / MA, from SEC Form 4 filings since May 25, 2022.

Recent trades

DateStockTradeValue
Feb 25, 2026VRTX Vertex Pharmaceuticals Inc / MASold$325K
Feb 24, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$789K
Feb 18, 2026VRTX Vertex Pharmaceuticals Inc / MASold$387K
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$740K
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MASold$994K
Feb 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$928K
Feb 11, 2026VRTX Vertex Pharmaceuticals Inc / MASold$806K
Feb 10, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$408K
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Nov 17, 2025VRTX Vertex Pharmaceuticals Inc / MASold$1.1M
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—
Oct 30, 2025ETNB 89bio, IncSold (not open market)—

Companies traded

  • VRTX Vertex Pharmaceuticals Inc / MA: 13 sales, last Feb 25, 2026
  • ETNB 89bio, Inc: 2 sales, last Oct 30, 2025

Get free alerts when Edward Morrow Atkinson III files a new trade →